PVI
BSTC

Pura Vida Investments’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Pura Vida Investments’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,160
Closed -$1.18M – 131
2018
Q3 		$1.18M Buy
+20,160
New +$1.03M 0.25% 79

Other funds holding BSTC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Pura Vida Investments's BSTC Position: Q4 2018 in Review

Pura Vida Investments sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2018, closing a stake of 20,160 shares — an estimated $1.18M sold.

Pura Vida Investments first reported a position in BSTC in Q3 2018 and held it in 1 quarter. The position peaked at $1.18M in Q3 2018. 107 funds tracked by Wall St. Rank hold BSTC as of Q4 2018.

  • Pura Vida Investments reported no remaining BioSpecifics Technologies Corp. position as of Q4 2018 after selling out during the quarter.
  • Pura Vida Investments sold 20,160 BioSpecifics Technologies Corp. shares in Q4 2018, an estimated $1.18M.
  • Pura Vida Investments first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 1 quarter.
  • Pura Vida Investments's BioSpecifics Technologies Corp. position peaked at $1.18M in Q3 2018.
  • 107 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.